Frontline Plc

Discover which maritime shipper offers better value and lower risk exposure.

fool.com - 2026-07-16 07:43:01

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.1%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.

seekingalpha.com - 2026-07-11 08:15:00

Oil prices jumped about 5% on Wednesday as renewed tensions involving Iran reignited fears of supply disruptions in the Middle East. But the bigger move wasn't in crude.

benzinga.com - 2026-07-08 13:35:44

When Iran attempted to impose transit tolls on ships through the Strait of Hormuz this spring, Secretary of State Marco Rubio dismissed it as illegal: “No country is allowed to charge tolls or fees on an international waterway.

247wallst.com - 2026-07-07 17:32:19

SAN CARLOS, Calif.--(BUSINESS WIRE)---- $ONC #BeOne--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the Phase 3 MANGROVE study (BGB-3111-306; NCT04002297) evaluating foundational BTK inhibitor BRUKINSA® (zanubrutinib) plus rituximab versus bendamustine plus rituximab (BR) in adult patients with previously untreated mantle cell lymphoma (MCL). MANGROVE is the first Phase 3, global, randomized trial to evaluate a BTK inhibito.

businesswire.com - 2026-06-30 06:00:00

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Mister Car Wash , one of the largest car wash companies in the United States, has successfully transformed its frontline employee experience by partnering with Staffbase , a leading provider of employee communication platforms. Through the launch of its branded app, Mister Connect, the company has established a single source of truth for its 7,000+ employees across more than 550 locations in 23 states.

globenewswire.com - 2026-06-25 11:00:00

The Middle East trade may be entering a new phase. Oil prices have retreated sharply this week as signs of progress in U.S.-Iran talks eased some fears of a broader regional disruption.

benzinga.com - 2026-06-18 11:03:26

SPARC AI engages Ukraine-based CFC Defence to lead its market-entry programme for Overwatch, accelerating drone OEM partnerships and frontline adoption.

globenewswire.com - 2026-06-17 04:20:00

A Truth Social post from President Donald Trump may have handed tanker investors a new storyline.

benzinga.com - 2026-06-12 12:24:00

While global crude prices have retreated beneath the critical $90 per barrel support level, the underlying shipping market is telling a different story as four major oil tanker stocks simultaneously surge into top-tier momentum zones.

benzinga.com - 2026-06-12 04:21:44

CHICAGO, June 11, 2026 (GLOBE NEWSWIRE) -- Quetzal Therapeutics, a biopharmaceutical company focused on developing therapies for rare hematologic malignancies, today announced that the first patient has been dosed in QUATRO-APL, the company's global Phase 3 clinical trial evaluating QTX-2101, an investigational oral capsule formulation of arsenic trioxide, in combination with all-trans retinoic acid (ATRA), for the treatment of patients with newly diagnosed, low-risk Acute Promyelocytic Leukemia, or APL.

globenewswire.com - 2026-06-11 06:52:00

On June 09, 2026, Frontline PLC (FRO) shares rose 3.6%, bringing the current price to $36.27. This increase comes amid a 52-week range that saw the stock hit a

gurufocus.com - 2026-06-09 19:46:00

Frontline plc is rated a Strong Buy due to its spot-rate exposure, robust dividend policy, and favorable market dynamics. FRO's nearly 100% spot-rate fleet and young vessel profile position it to fully capitalize on surging TCE rates and market volatility. The dividend yield is currently 17.63% and could rise above 30% if spot rates persist, supported by strong cash generation and low breakeven costs.

seekingalpha.com - 2026-06-09 09:33:56

Shipping ETFs are riding on elevated freight rates as Middle East disruptions reshape logistics, with BWET SEA posting strong 2026 gains.

zacks.com - 2026-06-05 09:40:33

Frontline is benefiting from an exceptionally strong tanker-rate environment, driving record profitability and robust cash flow. Q1 2026 delivered adjusted EPS of $1.55, $714.2M revenue, and a $1.55/share dividend, with forward fixtures indicating even higher earnings in Q2. FRO trades at a compressed multiple (trailing PE 8.5x, forward PE 4.5x) despite near-peak earnings, supporting a buy rating.

seekingalpha.com - 2026-06-03 10:40:56

President Trump told Fox Business this week he would hold the line on Iran sanctions.

247wallst.com - 2026-05-29 08:15:15

On May 27, 2026, Frontline PLC (FRO) shares fell 3.0% today, trading at $35.46. This price movement comes amid a 52-week range of $16.25 to $39.89, highlighting

gurufocus.com - 2026-05-27 19:41:00

Frontline plc (FRO) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-22 11:40:43

Frontline NYSE: FRO reported what Chief Executive Officer Lars Barstad called the company's most profitable quarter since 2004, as tanker markets were reshaped by the effective closure of the Strait of Hormuz and shifting global oil trade patterns.

marketbeat.com - 2026-05-22 11:10:18

CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced positive results from its Phase 2 trial of silevertinib in frontline (1L) non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) non-classical mutations (NCMs). These data will be presented by Julia Rotow, M.D., Clinical Director, Lowe Center for Thoracic Oncology at the Dana-Farber Cancer Institute, at the 2026 American Society of Clinical Oncology® (ASCO®) Annual Meeting on Saturday, May 30, 2026, 1:15 PM-2:45 PM CDT.

globenewswire.com - 2026-05-21 17:13:00

NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Continuing a decades-long commitment to driving innovation in public safety, emergency response and community resilience, Verizon today announced the winner of its first-ever Verizon Frontline App Developer Challenge.

globenewswire.com - 2026-05-20 13:00:00

Persistent inflation, higher oil prices, and geopolitical tensions continue supporting income-oriented sectors tied to energy and select financials. Tanker shipping and refining companies can benefit from disrupted trade routes, tighter fuel markets, and stronger cash flow during energy market dislocations. Higher-rate financials and cash-generating companies may provide defensive income opportunities as investors prepare for continued volatility surrounding inflation and midterm elections.

seekingalpha.com - 2026-05-19 15:16:56

On May 11, 2026, Frontline PLC (FRO) shares fell 3.4%, closing at $38.15. The stock has seen significant movement over the past year, with a 52-week range betwe

gurufocus.com - 2026-05-12 00:58:00

Small-cap stocks may lead after Fed rate cuts, giving individual investors an edge Wall Street is too big to use.

investorplace.com - 2026-05-11 00:00:00

Program Enters Final Stage of Dose Optimization Data Continue to Demonstrate Strong Clinical Activity and Favorable Safety Across an Expanding Frontline Dataset SEATTLE, WA / ACCESS Newswire / May 6, 2026 / Aptevo Therapeutics Inc. (Nasdaq:APVO) today reported new clinical results from its RAINIER frontline acute myeloid leukemia (AML) trial. The Company is on track to complete the Phase 1b dose-optimization trial and select the recommended Phase 2 dose (RP2D) this year.

accessnewswire.com - 2026-05-06 08:05:00

This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering significant discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields 4.74%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 8%.

seekingalpha.com - 2026-05-02 08:00:00

Frontline is the largest listed pure-play crude oil tanker company, operating a young and efficient fleet of 81 vessels. Recent VLCC rate spikes above $100k/day reflect a multi-year structural trend, not a transient event, supporting FRO's positive outlook. Global tanker supply is constrained by aging fleets, limited newbuild slots, and tankers tied up in the shadow fleet, tightening effective capacity.

seekingalpha.com - 2026-04-27 15:05:08

Zovegalisib + atirmociclib + AI selected as triplet regimen for frontline development Compelling efficacy and tolerability data for zovegalisib triplet in median 3L patients 44% ORR in heavily pre-treated, CDK4/6-experienced patients (median third-line); ORR is similar across kinase and non-kinase PIK3CA mutations Phase 3 frontline trial in endocrine sensitive patients expected to initiate in early 2027, subject to regulatory feedback Supply agreement in place with Pfizer to supply atirmociclib for the Phase 3 frontline trial Relay Therapeutics to host a conference call today, April 27, at 8:30am ET CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease, today announced plans to move zovegalisib + atirmociclib, Pfizer's investigational, potential first-in-class CDK4 inhibitor, into Phase 3 development for frontline patients with PI3Kα-mutated, HR+/HER2- metastatic breast cancer.

globenewswire.com - 2026-04-27 06:00:00

Wayne, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- Frontline Education, a leading provider of administration software purpose-built for K-12, today announced a series of advancements that accelerate its AI innovation across K-12—building momentum in how the company is applying AI to support school systems in the work ahead.

globenewswire.com - 2026-04-22 08:01:00

CAMBRIDGE, Mass., April 21, 2026 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer, today announced multiple presentations at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting from May 29 – June 2, 2026, in Chicago.

globenewswire.com - 2026-04-21 10:40:00